HCV - Liver Transplantation
Selected Hepatitis C Patients with Decompensated Cirrhosis Can Benefit from Interferon-based Therapy prior to Liver Transplantation - 6/10/08Marijuana Use Sparks Liver Transplant Controversy - 6/06/08FibroScan Liver Stiffness Measurement Distinguishes Fast and Slow Fibrosis Patterns after Liver Transplantation - 5/16/08
Prophylaxis with Pegylated Interferon Alfa-2a (Pegasys) plus Ribavirin vs No Prophylaxis after Liver Transplantation - 11/27/07 Sodium Levels Can Help Predict Outcomes before and after Liver Transplantation - 8/07/07 Treatment of Recurrent Hepatitis C in Liver Transplant Recipients - 7/10/07
Response to PegIntron/ribavirin Leads to Stabilization of Fibrosis in Liver Transplant Recipients - 5/01/07
Pegylated Interferon/ribavirin Therapy Results in Low SVR Rates after Liver Transplantation in HIV-HCV Coinfected Patients - 3/27/07
Sustained Virological Response Improves Fibrosis Progression and Reduces Mortality after Liver Transplantation 2/23/07
FDA-approved Combination Therapies for Chronic HCV Infection
Pegasys + Copegus PEG-Intron + Rebetol Intron A + Rebetol Roferon A + Ribavirin Treatment Guidelines
HCV Articles by Topic
HCV Liver Issues Cirrhosis Fibrosis Hepatocellular Carcinoma Liver Transplantation Liver Biopsy Steatosis
FDA-approved
Treatments Experimental
Treatments
HCV
Articles by Topic
